Tirzepatide Research
Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics
BMJ Open Diabetes Research & Care·March 30, 2026
John P. H. Wilding, et al.
Summary
Safety and efficacy analysis of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics.
Study Details
Study Design
Analysis across baseline characteristics
Indication
Type 2 diabetes
Intervention
Switch from dulaglutide to tirzepatide
Species
Human